NexgenRx Inc.
NXG.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 255.50K | 367.30K | -19.70K | 109.40K | 23.30K |
| Total Depreciation and Amortization | 233.40K | 218.80K | -466.40K | 227.10K | 235.50K |
| Total Amortization of Deferred Charges | -- | -- | 691.90K | -- | -- |
| Total Other Non-Cash Items | -11.50K | -9.00K | 316.50K | -9.70K | 15.90K |
| Change in Net Operating Assets | 274.40K | -331.50K | -350.30K | -229.80K | 470.10K |
| Cash from Operations | 751.80K | 245.70K | 172.00K | 97.10K | 744.80K |
| Capital Expenditure | -186.70K | -23.70K | -20.60K | -5.60K | -22.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -87.40K | -42.90K | -179.40K | -43.70K | -93.60K |
| Cash from Investing | -274.00K | -66.60K | -200.00K | -49.30K | -116.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -34.00K | -34.00K | -31.00K | -26.50K | -24.10K |
| Issuance of Common Stock | -- | -- | 0.00 | 62.50K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -280.90K | -23.00K | -72.80K | -24.20K | -283.30K |
| Other Financing Activities | -- | -- | 33.00K | -33.00K | -- |
| Cash from Financing | -305.40K | -46.70K | -71.40K | -22.00K | -300.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 172.40K | 132.40K | -99.30K | 25.70K | 327.80K |